Axa S.A. Has $50.51 Million Position in CVS Health Corporation $CVS

Axa S.A. trimmed its position in CVS Health Corporation (NYSE:CVS) by 2.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 732,229 shares of the pharmacy operator’s stock after selling 18,666 shares during the period. Axa S.A. owned approximately 0.06% of CVS Health worth $50,509,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of CVS. Avion Wealth increased its position in shares of CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 189 shares in the last quarter. Harbor Asset Planning Inc. acquired a new position in CVS Health in the second quarter valued at about $30,000. Bell Investment Advisors Inc increased its holdings in shares of CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 248 shares in the last quarter. Roxbury Financial LLC raised its position in shares of CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 202 shares during the period. Finally, ORG Partners LLC lifted its holdings in shares of CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 377 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Cantor Fitzgerald raised their price objective on shares of CVS Health from $78.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, October 30th. Weiss Ratings reissued a “hold (c-)” rating on shares of CVS Health in a research report on Monday. Jefferies Financial Group boosted their price target on CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. The Goldman Sachs Group began coverage on CVS Health in a report on Tuesday, October 14th. They issued a “buy” rating and a $91.00 price objective for the company. Finally, Truist Financial restated a “buy” rating and set a $95.00 target price (up from $92.00) on shares of CVS Health in a report on Thursday, October 30th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $91.67.

CVS Health Trading Up 2.3%

Shares of NYSE:CVS opened at $78.31 on Wednesday. The stock has a market cap of $99.41 billion, a PE ratio of 206.08, a P/E/G ratio of 0.75 and a beta of 0.48. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $85.15. The business has a 50 day moving average of $78.82 and a 200-day moving average of $71.59.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. During the same period in the previous year, the company posted $1.09 EPS. The firm’s quarterly revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were paid a $0.665 dividend. The ex-dividend date was Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.4%. CVS Health’s payout ratio is 700.00%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.